Protembis GmbH: Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal Trial finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
NEW YORK & AACHEN, Germany, April 02, 2024 Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the enrollment of the first patient in the PROTEMBO Investigational Device Exemption (IDE) Pivotal Trial (NCT05873816). The trial will enroll between 250-500 randomized patients undergoing transcatheter aortic valve replacement (TAVR) in the USA and Europe with the ProtEmbo® System, an innovative next generation cerebral embolic protection devic
Protembis Announces FDA Approval of its Pivotal Investigational Device Exemption (IDE) Study tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Um erneut in den Bundestag zu kommen, muss der 66-jährige Bernhard Loos für die CSU den "schwierigsten Wahlkreis in ganz Bayern" gewinnen. Er will die technologische Transformation vorantreiben